← All organizations

Ikena Oncology

For profitWebsite ↗

Also known as: Ikena Oncology

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

Dec 18, 2023

Timeline

2010s

Jun 1, 2016
Ikena Oncology— Founded
Jan 1, 2018
Arrys Therapeutics— Acquired

2020s

Aug 7, 2023
Pionyr Immunotherapeutics Inc.— Acquired

Drugs by trial phase (9 distinct, 8 trials)

Phase 2 (0 own, 2 via acquisition)

Phase 1 (5 own, 2 via acquisition)

Indications

Studied for

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (11)

NCT06270082OfficialPhase 1Dec 18, 2023
NCT06270082Lead sponsorPhase 1Dec 18, 2023
NCT05472506OfficialPhase 1Sep 30, 2022
NCT05472506Lead sponsorPhase 1Sep 30, 2022
NCT05472506Study chairPhase 1Sep 30, 2022
NCT05472506Study directorPhase 1Sep 30, 2022
NCT05228015Lead sponsorPhase 1Jan 7, 2022
NCT05228015Study chairPhase 1Jan 7, 2022
NCT05228015Study directorPhase 1Jan 7, 2022
NCT04200963Lead sponsorPhase 1Dec 31, 2019
NCT04200963Study directorPhase 1Dec 31, 2019

Details

Founded: Cambridge, MA, US Jun 1, 2016
Last known activity: Dec 18, 2023